Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019; 21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022; 24(4):E319-325. doi:
10.1001/amajethics.2022.319.
Mark Gilbert, PhD, Leanne Picketts, MEd, Anna MacLeod, PhD, and Wendy A. Stewart, MD, MMEd, PhD
This study offers an arts-based tool set capable of being delivered within the familiar medical education setting and established structure of the OSCE.
AMA J Ethics. 2022; 24(7):E556-562. doi:
10.1001/amajethics.2022.556.
Sophia Miao, MD and Wendy A. Stewart, MD, MMEd, PhD
This pilot study used phenomenology combined with quantitative measures of self-esteem and self-efficacy to explore influences of storytelling through lyrical and musical composition on youth self-concept.
AMA J Ethics. 2022; 24(7):E576-583. doi:
10.1001/amajethics.2022.576.